Not all individuals with CLL require therapy. In spite of all recent advances, the iwCLL nonetheless recommends watchful observation for clients with asymptomatic disorder.86 This recommendation relies on not less than two randomized trials comparing observation to both chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).P